Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 12 March, 2025
Author: Getaka|Social: Getaka Financial Technology X (Earlier Twitter) Profile Getaka Financial Technology LinkedIn Logo

Expleo Solutions Ltd: Share Price Analysis, Intrinsic Value & Fundamentals (2025)

Share Price and Basic Stock Data

Last Updated: March 8, 2025, 8:00 pm

Market Cap 1,382 Cr.
Current Price 890
High / Low 1,567/824
Stock P/E14.6
Book Value 432
Dividend Yield5.62 %
ROCE20.5 %
ROE15.9 %
Face Value 10.0
PEG Ratio3.29

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Expleo Solutions Ltd

Competitors of Expleo Solutions Ltd

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Visesh Infotecnics Ltd 125 Cr. 0.33 0.57/0.33 1.140.00 %0.88 %0.82 % 1.00
Mudunuru Ltd 22.6 Cr. 7.23 15.6/5.41 0.340.00 %72.9 %374 % 2.00
Naapbooks Ltd 94.7 Cr. 105 159/54.040.6 20.00.00 %17.4 %13.6 % 10.0
IB Infotech Enterprises Ltd 21.1 Cr. 165 245/11327.1 16.80.61 %69.9 %50.5 % 10.0
Hit Kit Global Solutions Ltd 7.19 Cr. 1.55 1.55/0.9120.0 2.080.00 %1.92 %1.94 % 2.00
Industry Average19,195.34 Cr566.7379.98121.670.84%21.53%64.55%6.83

All Competitor Stocks of Expleo Solutions Ltd

Quarterly Result

MetricDec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
Sales 106196212220240231225234250255252259258
Expenses 89166176178168188192200212221213217219
Operating Profit 17303742724333343834394239
OPM % 16%15%17%19%30%19%15%14%15%13%15%16%15%
Other Income 0611134221122133
Interest 0100101111111
Depreciation 257777888991012
Profit before tax 15303136773926274126314428
Tax % 26%28%25%33%28%26%22%24%16%40%23%20%30%
Net Profit 11222324552920213416243520
EPS in Rs 11.1021.2022.3923.3854.0028.3413.0113.2221.9310.1215.4022.8712.75

Last Updated: February 28, 2025, 8:08 pm

Below is a detailed analysis of the quarterly data for Expleo Solutions Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

  • For Sales, as of Dec 2024, the value is ₹258.00 Cr.. The value appears to be declining and may need further review. It has decreased from 259.00 Cr. (Sep 2024) to ₹258.00 Cr., marking a decrease of 1.00 Cr..
  • For Expenses, as of Dec 2024, the value is ₹219.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 217.00 Cr. (Sep 2024) to ₹219.00 Cr., marking an increase of ₹2.00 Cr..
  • For Operating Profit, as of Dec 2024, the value is ₹39.00 Cr.. The value appears to be declining and may need further review. It has decreased from 42.00 Cr. (Sep 2024) to ₹39.00 Cr., marking a decrease of 3.00 Cr..
  • For OPM %, as of Dec 2024, the value is 15.00%. The value appears to be declining and may need further review. It has decreased from 16.00% (Sep 2024) to 15.00%, marking a decrease of 1.00%.
  • For Other Income, as of Dec 2024, the value is ₹3.00 Cr.. The value appears to be declining and may need further review. It has decreased from 13.00 Cr. (Sep 2024) to ₹3.00 Cr., marking a decrease of 10.00 Cr..
  • For Interest, as of Dec 2024, the value is ₹1.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 1.00 Cr..
  • For Depreciation, as of Dec 2024, the value is ₹12.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 10.00 Cr. (Sep 2024) to ₹12.00 Cr., marking an increase of ₹2.00 Cr..
  • For Profit before tax, as of Dec 2024, the value is ₹28.00 Cr.. The value appears to be declining and may need further review. It has decreased from 44.00 Cr. (Sep 2024) to ₹28.00 Cr., marking a decrease of 16.00 Cr..
  • For Tax %, as of Dec 2024, the value is 30.00%. The value appears to be increasing, which may not be favorable. It has increased from 20.00% (Sep 2024) to 30.00%, marking an increase of 10.00%.
  • For Net Profit, as of Dec 2024, the value is ₹20.00 Cr.. The value appears to be declining and may need further review. It has decreased from 35.00 Cr. (Sep 2024) to ₹20.00 Cr., marking a decrease of 15.00 Cr..
  • For EPS in Rs, as of Dec 2024, the value is 12.75. The value appears to be declining and may need further review. It has decreased from ₹22.87 (Sep 2024) to 12.75, marking a decrease of ₹10.12.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 6, 2025, 4:21 pm

MetricMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024TTM
Sales 1611942142642602712832703017439039651,024
Expenses 131155177210219231230217231618703816871
Operating Profit 304037544140535370124200149154
OPM % 19%20%17%20%16%15%19%20%23%17%22%15%15%
Other Income 21026113685616720
Interest 1220000111233
Depreciation 56545666619283440
Profit before tax 264232563748545468110186120130
Tax % 27%29%32%34%36%33%32%26%26%39%28%24%
Net Profit 193022372432364050681349095
EPS in Rs 19.2029.2620.5334.6822.2929.8633.7938.9249.2066.01130.5958.2761.14
Dividend Payout % 31%31%117%69%108%80%0%0%0%0%6%0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2013-20142014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-2024
YoY Net Profit Growth (%)57.89%-26.67%68.18%-35.14%33.33%12.50%11.11%25.00%36.00%97.06%-32.84%
Change in YoY Net Profit Growth (%)0.00%-84.56%94.85%-103.32%68.47%-20.83%-1.39%13.89%11.00%61.06%-129.89%

Expleo Solutions Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.

No data available for the compounded sales growth chart.

Balance Sheet

Last Updated: December 14, 2024, 3:40 pm

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Sep 2024
Equity Capital 10101111111111101016161616
Reserves 78989198116118128142192379515596655
Borrowings 14121000000715262633
Other Liabilities 262754734363536256185174128172
Total Liabilities 128147165182171191192214264594730765876
Fixed Assets 312724252722192625108142131134
CWIP 0110000006650
Investments 00000000000150
Other Assets 97119139157144169173188239480582614742
Total Assets 128147165182171191192214264594730765876

Below is a detailed analysis of the balance sheet data for Expleo Solutions Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

  • For Equity Capital, as of Sep 2024, the value is ₹16.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹16.00 Cr..
  • For Reserves, as of Sep 2024, the value is ₹655.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹596.00 Cr. (Mar 2024) to ₹655.00 Cr., marking an increase of 59.00 Cr..
  • For Borrowings, as of Sep 2024, the value is ₹33.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from ₹26.00 Cr. (Mar 2024) to ₹33.00 Cr., marking an increase of 7.00 Cr..
  • For Other Liabilities, as of Sep 2024, the value is ₹172.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹128.00 Cr. (Mar 2024) to ₹172.00 Cr., marking an increase of 44.00 Cr..
  • For Total Liabilities, as of Sep 2024, the value is ₹876.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹765.00 Cr. (Mar 2024) to ₹876.00 Cr., marking an increase of 111.00 Cr..
  • For Fixed Assets, as of Sep 2024, the value is ₹134.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹131.00 Cr. (Mar 2024) to ₹134.00 Cr., marking an increase of 3.00 Cr..
  • For CWIP, as of Sep 2024, the value is ₹0.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹5.00 Cr. (Mar 2024) to ₹0.00 Cr., marking a decrease of 5.00 Cr..
  • For Investments, as of Sep 2024, the value is ₹0.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹15.00 Cr. (Mar 2024) to ₹0.00 Cr., marking a decrease of 15.00 Cr..
  • For Other Assets, as of Sep 2024, the value is ₹742.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹614.00 Cr. (Mar 2024) to ₹742.00 Cr., marking an increase of 128.00 Cr..
  • For Total Assets, as of Sep 2024, the value is ₹876.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹765.00 Cr. (Mar 2024) to ₹876.00 Cr., marking an increase of 111.00 Cr..

Notably, the Reserves (₹655.00 Cr.) exceed the Borrowings (33.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

No data available for this post.

Free Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Free Cash Flow16.0028.0027.0054.0041.0040.0053.0053.0063.00109.00174.00123.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Debtor Days93105977560925910374859794
Inventory Days
Days Payable
Cash Conversion Cycle93105977560925910374859794
Working Capital Days626823-78211550504894114
ROCE %31%40%29%51%31%38%40%38%39%36%39%20%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthSep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
Promoters56.17%56.17%56.17%56.17%56.17%56.17%56.17%71.05%71.05%71.05%71.05%71.05%
FIIs0.17%0.09%0.13%0.00%0.08%0.01%0.01%0.15%0.00%0.03%0.04%0.06%
DIIs1.83%2.16%2.08%2.39%3.35%4.52%4.74%2.92%2.73%3.26%2.37%1.83%
Government0.00%0.00%0.00%0.00%0.00%0.00%0.01%0.00%0.00%0.00%0.00%0.00%
Public41.83%41.58%41.62%41.44%40.39%39.30%39.07%25.87%26.22%25.67%26.56%27.06%
No. of Shareholders18,24521,42521,98121,64922,02521,23620,67121,83125,65127,17929,46229,083

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Invesco India Multicap Fund133,9720.6617.73127,9852025-03-074.68%
Invesco India Smallcap Fund127,9850.5916.93127,9852025-03-070%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 58.2786.2752.5849.2038.51
Diluted EPS (Rs.) 58.2786.2752.5849.2038.51
Cash EPS (Rs.) 79.96157.7960.3254.8644.60
Book Value[Excl.RevalReserv]/Share (Rs.) 393.78512.06248.93196.90148.46
Book Value[Incl.RevalReserv]/Share (Rs.) 393.78512.06248.93196.90148.46
Revenue From Operations / Share (Rs.) 621.69881.09394.57293.50262.78
PBDIT / Share (Rs.) 100.42210.9378.8573.4259.49
PBIT / Share (Rs.) 78.73183.7371.1167.7553.81
PBT / Share (Rs.) 77.05181.5370.3766.7252.73
Net Profit / Share (Rs.) 58.27130.6052.5849.2038.92
NP After MI And SOA / Share (Rs.) 58.27130.6052.5849.2038.92
PBDIT Margin (%) 16.1523.9319.9825.0122.63
PBIT Margin (%) 12.6620.8518.0223.0820.47
PBT Margin (%) 12.3920.6017.8322.7320.06
Net Profit Margin (%) 9.3714.8213.3216.7614.81
NP After MI And SOA Margin (%) 9.3714.8213.3216.7614.81
Return on Networth / Equity (%) 14.7925.5021.1224.9826.21
Return on Capital Employeed (%) 18.4833.4827.1133.1634.35
Return On Assets (%) 11.8218.3315.6519.0818.62
Asset Turnover Ratio (%) 1.291.841.461.361.43
Current Ratio (X) 5.773.303.844.113.30
Quick Ratio (X) 5.773.303.844.113.30
Dividend Payout Ratio (NP) (%) 8.580.000.000.000.00
Dividend Payout Ratio (CP) (%) 6.250.000.000.000.00
Earning Retention Ratio (%) 91.420.000.000.000.00
Cash Earning Retention Ratio (%) 93.750.000.000.000.00
Interest Coverage Ratio (X) 59.7495.85106.5171.2855.04
Interest Coverage Ratio (Post Tax) (X) 35.6660.3572.0248.7737.01
Enterprise Value (Cr.) 1697.971111.701571.40398.5262.33
EV / Net Operating Revenue (X) 1.761.233.881.320.23
EV / EBITDA (X) 10.895.1419.445.291.02
MarketCap / Net Operating Revenue (X) 1.951.404.271.760.55
Retention Ratios (%) 91.410.000.000.000.00
Price / BV (X) 3.082.416.772.620.98
Price / Net Operating Revenue (X) 1.951.404.271.760.55
EarningsYield 0.040.100.030.090.26

After reviewing the key financial ratios for Expleo Solutions Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
  • For Basic EPS (Rs.), as of Mar 24, the value is 58.27. This value is within the healthy range. It has decreased from 86.27 (Mar 23) to 58.27, marking a decrease of 28.00.
  • For Diluted EPS (Rs.), as of Mar 24, the value is 58.27. This value is within the healthy range. It has decreased from 86.27 (Mar 23) to 58.27, marking a decrease of 28.00.
  • For Cash EPS (Rs.), as of Mar 24, the value is 79.96. This value is within the healthy range. It has decreased from 157.79 (Mar 23) to 79.96, marking a decrease of 77.83.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 393.78. It has decreased from 512.06 (Mar 23) to 393.78, marking a decrease of 118.28.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 393.78. It has decreased from 512.06 (Mar 23) to 393.78, marking a decrease of 118.28.
  • For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 621.69. It has decreased from 881.09 (Mar 23) to 621.69, marking a decrease of 259.40.
  • For PBDIT / Share (Rs.), as of Mar 24, the value is 100.42. This value is within the healthy range. It has decreased from 210.93 (Mar 23) to 100.42, marking a decrease of 110.51.
  • For PBIT / Share (Rs.), as of Mar 24, the value is 78.73. This value is within the healthy range. It has decreased from 183.73 (Mar 23) to 78.73, marking a decrease of 105.00.
  • For PBT / Share (Rs.), as of Mar 24, the value is 77.05. This value is within the healthy range. It has decreased from 181.53 (Mar 23) to 77.05, marking a decrease of 104.48.
  • For Net Profit / Share (Rs.), as of Mar 24, the value is 58.27. This value is within the healthy range. It has decreased from 130.60 (Mar 23) to 58.27, marking a decrease of 72.33.
  • For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 58.27. This value is within the healthy range. It has decreased from 130.60 (Mar 23) to 58.27, marking a decrease of 72.33.
  • For PBDIT Margin (%), as of Mar 24, the value is 16.15. This value is within the healthy range. It has decreased from 23.93 (Mar 23) to 16.15, marking a decrease of 7.78.
  • For PBIT Margin (%), as of Mar 24, the value is 12.66. This value is within the healthy range. It has decreased from 20.85 (Mar 23) to 12.66, marking a decrease of 8.19.
  • For PBT Margin (%), as of Mar 24, the value is 12.39. This value is within the healthy range. It has decreased from 20.60 (Mar 23) to 12.39, marking a decrease of 8.21.
  • For Net Profit Margin (%), as of Mar 24, the value is 9.37. This value is within the healthy range. It has decreased from 14.82 (Mar 23) to 9.37, marking a decrease of 5.45.
  • For NP After MI And SOA Margin (%), as of Mar 24, the value is 9.37. This value is within the healthy range. It has decreased from 14.82 (Mar 23) to 9.37, marking a decrease of 5.45.
  • For Return on Networth / Equity (%), as of Mar 24, the value is 14.79. This value is below the healthy minimum of 15. It has decreased from 25.50 (Mar 23) to 14.79, marking a decrease of 10.71.
  • For Return on Capital Employeed (%), as of Mar 24, the value is 18.48. This value is within the healthy range. It has decreased from 33.48 (Mar 23) to 18.48, marking a decrease of 15.00.
  • For Return On Assets (%), as of Mar 24, the value is 11.82. This value is within the healthy range. It has decreased from 18.33 (Mar 23) to 11.82, marking a decrease of 6.51.
  • For Asset Turnover Ratio (%), as of Mar 24, the value is 1.29. It has decreased from 1.84 (Mar 23) to 1.29, marking a decrease of 0.55.
  • For Current Ratio (X), as of Mar 24, the value is 5.77. This value exceeds the healthy maximum of 3. It has increased from 3.30 (Mar 23) to 5.77, marking an increase of 2.47.
  • For Quick Ratio (X), as of Mar 24, the value is 5.77. This value exceeds the healthy maximum of 2. It has increased from 3.30 (Mar 23) to 5.77, marking an increase of 2.47.
  • For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 8.58. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 23) to 8.58, marking an increase of 8.58.
  • For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 6.25. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 23) to 6.25, marking an increase of 6.25.
  • For Earning Retention Ratio (%), as of Mar 24, the value is 91.42. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 23) to 91.42, marking an increase of 91.42.
  • For Cash Earning Retention Ratio (%), as of Mar 24, the value is 93.75. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 23) to 93.75, marking an increase of 93.75.
  • For Interest Coverage Ratio (X), as of Mar 24, the value is 59.74. This value is within the healthy range. It has decreased from 95.85 (Mar 23) to 59.74, marking a decrease of 36.11.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 35.66. This value is within the healthy range. It has decreased from 60.35 (Mar 23) to 35.66, marking a decrease of 24.69.
  • For Enterprise Value (Cr.), as of Mar 24, the value is 1,697.97. It has increased from 1,111.70 (Mar 23) to 1,697.97, marking an increase of 586.27.
  • For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.76. This value is within the healthy range. It has increased from 1.23 (Mar 23) to 1.76, marking an increase of 0.53.
  • For EV / EBITDA (X), as of Mar 24, the value is 10.89. This value is within the healthy range. It has increased from 5.14 (Mar 23) to 10.89, marking an increase of 5.75.
  • For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.95. This value is within the healthy range. It has increased from 1.40 (Mar 23) to 1.95, marking an increase of 0.55.
  • For Retention Ratios (%), as of Mar 24, the value is 91.41. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 23) to 91.41, marking an increase of 91.41.
  • For Price / BV (X), as of Mar 24, the value is 3.08. This value exceeds the healthy maximum of 3. It has increased from 2.41 (Mar 23) to 3.08, marking an increase of 0.67.
  • For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.95. This value is within the healthy range. It has increased from 1.40 (Mar 23) to 1.95, marking an increase of 0.55.
  • For EarningsYield, as of Mar 24, the value is 0.04. This value is below the healthy minimum of 5. It has decreased from 0.10 (Mar 23) to 0.04, marking a decrease of 0.06.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Expleo Solutions Ltd as of March 12, 2025 is: ₹847.36

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of March 12, 2025, Expleo Solutions Ltd is Overvalued by 4.79% compared to the current share price 890.00

Intrinsic Value of Expleo Solutions Ltd as of March 12, 2025 is: 884.99

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of March 12, 2025, Expleo Solutions Ltd is Overvalued by 0.56% compared to the current share price 890.00

Last 5 Year EPS CAGR: 4.44%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a high average ROCE of 36.00%, which is a positive sign.
  2. The company has higher reserves (246.62 cr) compared to borrowings (11.00 cr), indicating strong financial stability.
  3. The company has shown consistent growth in sales (371.54 cr) and profit (74.08 cr) over the years.
  1. The stock has a high average Working Capital Days of 45.50, which may not be favorable.
  2. The stock has a high average Cash Conversion Cycle of 86.17, which may not be favorable.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Expleo Solutions Ltd:
    1. Net Profit Margin: 9.37%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 18.48% (Industry Average ROCE: 21.53%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 14.79% (Industry Average ROE: 64.55%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 35.66
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 5.77
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 14.6 (Industry average Stock P/E: 79.98)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Expleo Solutions Ltd. is a Public Limited Listed company incorporated on 08/06/1998 and has its registered office in the State of Tamil Nadu, India. Company's Corporate Identification Number(CIN) is L64202TN1998PLC066604 and registration number is 066604. Currently Company is involved in the business activities of Writing , modifying, testing of computer program to meet the needs of a particular client excluding web-page designing. Company's Total Operating Revenue is Rs. 964.87 Cr. and Equity Capital is Rs. 15.52 Cr. for the Year ended 31/03/2024.
INDUSTRYADDRESSCONTACT
IT Consulting & Software6A, Sixth Floor, Prince Infocity II, Chennai (Madras) Tamil Nadu 600096investor.expleosol@expleogroup.com
https://www.investors.expleo.com
Management
NamePosition Held
Mr. Ralph Franz GillessenChairman & Non-Exe.Director
Mr. Balaji ViswanathanManaging Director & CEO
Mr. Rajesh KrishnamurthyNon Executive Director
Ms. Lilian Jessie PaulIndependent Director
Mr. Narayanan SubramaniamIndependent Director
Dr. Srivardhini Keshavamurthy JhaIndependent Director
Dr. Varadharajan SridharIndependent Director
Ms. Shalini Kalsi KamathInd. Non-Executive Director

FAQ

What is the latest intrinsic value of Expleo Solutions Ltd?

The latest intrinsic value of Expleo Solutions Ltd as on 12 March 2025 is ₹847.36, which is 4.79% lower than the current market price of 890.00, indicating the stock is overvalued by 4.79%. The intrinsic value of Expleo Solutions Ltd is calculated using PE ratio method. The stock has a market capitalization of ₹1,382 Cr. and recorded a high/low of ₹1,567/824 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹655 Cr and total liabilities of ₹876 Cr.

What is the Market Cap of Expleo Solutions Ltd?

The Market Cap of Expleo Solutions Ltd is 1,382 Cr..

What is the current Stock Price of Expleo Solutions Ltd as on 12 March 2025?

The current stock price of Expleo Solutions Ltd as on 12 March 2025 is ₹890.

What is the High / Low of Expleo Solutions Ltd stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of Expleo Solutions Ltd stocks is ₹1,567/824.

What is the Stock P/E of Expleo Solutions Ltd?

The Stock P/E of Expleo Solutions Ltd is 14.6.

What is the Book Value of Expleo Solutions Ltd?

The Book Value of Expleo Solutions Ltd is 432.

What is the Dividend Yield of Expleo Solutions Ltd?

The Dividend Yield of Expleo Solutions Ltd is 5.62 %.

What is the ROCE of Expleo Solutions Ltd?

The ROCE of Expleo Solutions Ltd is 20.5 %.

What is the ROE of Expleo Solutions Ltd?

The ROE of Expleo Solutions Ltd is 15.9 %.

What is the Face Value of Expleo Solutions Ltd?

The Face Value of Expleo Solutions Ltd is 10.0.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Expleo Solutions Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE